Podcasts about Accreditation

The Joint Commission's updated accreditation manual is designed to simplify requirements, enhance clarity, and better support healthcare organizations in survey preparation. In this episode of VerifiedRx, host Carolyn Liptak is joined by Dr. Robert Campbell of the Joint Commission and Diana Scott of Vizient to unpack the most significant changes. From the shift to National Performance Goals and medication safety priorities to the latest challenges in compounding, labeling, and hazardous drug handling, the conversation highlights practical insights to help pharmacy leaders stay compliant and survey-ready.   Guest speakers: Robert Campbell, PharmD, BCSCP Sr. Director, Standards Interpretation, Accreditation Decision Management,Medication Safety Division of Accreditation and Certification Operations Joint Commission   Diana Scott, MHA, RN, CPHQ Principal, Regulatory and Accreditation Services Vizient   Host:  Carolyn Liptak, , BS Pharm, MBA   Vizient   Show Notes:  [01:16-01:51] Diana and Robert Backgrounds [01:52-02:43] Changes made to the hospital and critical access hospital manuals [02:44-03:09] Changes to the chapters themselves [03:10-04:08] National Performance Goals and elaborate on those that are relevant to medication safety and pharmacy services [04:09-05:15] The top medication management challenges [05:16-06:29] Pain management not being aligned and titration orders [06:30-06:56] Insufficient communication between pharmacists, prescribers and nurses when it comes to medication orders [06:57-08:02] Themes around labeling requirements for stored medications [08:03-08:46] Anything different in removing expired meds from patient care areas and in the pharmacy this area than previous years [08:47-10:58] Issues related to storing meds specifically per the package insert [10:59-11:55] Common issues seen inside the pharmacy regarding sterile compounding, noncompliance include hand hygiene, garbing, PPE, and cleaning and disinfecting [11:56-13:12] More specifics in those area the physical environment and facility cleanliness along with cleaning and disinfection practices [13:13-14:55] Explaination of how joint Commission defines and evaluates immediate use compounding [14:56-16:09] The minimum required elements for immediate use compounding competency [16:10-17:12] Compounding competencies besides immediate use [17:13-17:54] Expectations for environmental services training [17:55- 20:14] Concerns around hazardous drugs [20:15- 21:14] Additional information   Links | Resources: Joint Commission: THE NEW STANDARD: Accreditation 360   VerifiedRx Listener Feedback Survey: We would love to hear from you - Please click here   Subscribe Today! Apple Podcasts Spotify YouTube RSS Feed

“Policies help make sure that we're giving patients the right education and discharge instructions. Radiation doesn't end when the syringe is empty. Patients go home with potential radioactive exposure. They need to know how to protect their families, what precautions to take, and what healthcare providers can do if something goes wrong—like a spill, extravasation, or even a pregnant staff member who's involved in the care. This isn't just a documentation exercise. It's about making sure every part of the system speaks the same language when it comes to safety, handling, and patient care,” ONS member Ella-Mae Shupe, MSN, RN, OCN®, nursing practice and professional development specialist for radiation oncology at Johns Hopkins Health System Sydney Kimmel Cancer Center based in Baltimore, MD, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a conversation about creating and implementing radiopharmaceutical policies and procedures.  Music Credit: “Fireflies and Stardust” by Kevin MacLeod  Licensed under Creative Commons by Attribution 3.0   Earn 0.5 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by August 22, 2026. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.  Learning outcome: Learner will report an increase in knowledge related to implementing policies and procedures to support administration of radiopharmaceuticals for cancer treatment. Episode Notes   Complete this evaluation for free NCPD. ONS Podcast™ episodes: Episode 347: Care Considerations for Radiopharmaceuticals and Theranostics in Patients With Cancer Episode 301: Radiation Oncology: Side Effect and Care Coordination Best Practices Episode 298: Radiation Oncology: Nursing's Essential Roles Episode 104: How Radiation Affects All Areas of Oncology Nursing ONS Voice articles: New Radiopharmaceutical Improves Survival in Advanced Prostate Cancer Radiopharmaceuticals and Theranostics Offer New Options for Oncology Nurses to Transform Cancer Care Radiopharmaceuticals Pack a One-Two Punch Against Cancer Safety Is Key in Use of Radiopharmaceuticals ONS Voice oncology drug reference sheets: Lutetium Lu 177 Dotatate Lutetium Lu 177 Vipivotide Tetraxetan Radium 223 Dichloride Sodium Iodide-131 ONS book: Manual for Radiation Oncology Nursing Practice and Education (Fifth Edition) ONS course: ONS/ONCC® Radiation Therapy Certificate™ Clinical Journal of Oncology Nursing article: Nursing Telemedicine Educational Encounters: Improved Patient Satisfaction in Radiation Therapy Clinics Other ONS resources: ONS Radiation Learning Library ONS Radiation Safety: In the Home Huddle Card ONS Radiopharmaceuticals Huddle Card Daily Med Lutathera® website for healthcare professionals Pluvicto® website for healthcare professionals Xofigo® website for healthcare professionals To discuss the information in this episode with other oncology nurses, visit the ONS Communities.   To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library.  To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode  “[Lutetium lu 177 vipivotide tetraxetan] has shown so effective in clinical studies that the FDA recently approved expanded use, and it can now be given prior to chemotherapy.” TS 1:56 “There are typically three parts to a radiopharmaceutical. One is a radioisotope, which emits the radiation. The second is a targeting molecule, which directs the compound to a specific site. And the third is a linker that binds the isotope to the targeting molecules securely. The targeting molecule is usually a substance that binds specifically to receptors, antigens, or metabolic pathways that are overexpressed on cancer cells.” TS 2:08  “We have an interdisciplinary team involvement. There's a physicist, nurse, and provider that confirm lab values are within normal limits. The patient meets all the clinical and safety criteria for administration. Second is an IV placement where a nurse or clin tech starts the IV and verifies a strong blood return. This is critical to avoid extravasation, which can be harmful due to the vesicant-like nature of radiopharmaceuticals. And third, our patient voids immediately before the injection, which reduces bladder radiation dose. During the administration, our provider administers the radiopharmaceutical using a shielded syringe holder to reduce radiation exposure. The physicist remains present throughout the procedure. Lead aprons are worn by any team members close to the IV site, and then the Geiger counter is used by physics to measure ionizing radiation, which is done before, during, and after the procedure.” TS 3:28 “The policy we created doesn't just address general principles. It includes very specific guidance for both [radium 223 dichloride] and [lutetium lu 177 vipivotide tetraxetan]. That includes everything from determining patient eligibility to completing the treatment directive, confirming patient identity, verifying delivery parameters, documenting the treatment itself, and ensuring the treatment environment is appropriate and safe. We've also built in drug- specific practices because [radium 223 dichloride] and [lutetium lu 177 vipivotide tetraxetan] each come with their own considerations. This includes competencies for nursing, tailored patient education for each therapy, and an extravasation checklist that outlines what to do and who's responsible for tasks if infiltration occurs.”TS 11:24 “We created two separate versions [of an attestation model], one for clinical staff and one for non-clinical staff. Why include non-clinical staff? Because the risks extend beyond just the clinical team. What if environmental services comes in to clean and the patient has urinated on the floor? Or what if dietary delivers a tray and moves a urinal without knowing the risk? Or what if transport comes in and handles an incontinent brief without awareness? Each of these scenarios has potential for contamination and exposure. And that's exactly why education for all roles matter.” TS 15:22 “These are such an exciting treatment for our patients, that's not chemotherapy, that's not radiation, and their quality of life has been amazing. We have had patients coming in that could barely walk because of the pain from bone mets and after a few treatments, they're much better. We've had PSAs go from five, six hundreds down to 0.5, so we're seeing a lot of really good options for these patients and treatment.” TS 22:09  

In this comprehensive discussion, Bryan sits down with Brad Cooper, an experienced HVAC instructor from Arkansas, and JD Kelly, a trade school graduate, to tackle one of the most pressing questions in the HVAC industry: Is trade school worth it? Rather than offering a simple yes or no answer, the trio dives deep into the nuanced factors that determine whether trade school provides real value for aspiring HVAC technicians. The conversation begins with Brad's unique perspective as both a field technician with over 20 years of experience and a current instructor who transitioned to teaching five years ago. His father's business background and the common frustration of having to "go behind people and fix stuff" motivated Brad to enter education, believing that proper training from the start could eliminate many field problems. JD brings the student perspective, having attended trade school while working full-time, which gives him insight into both the challenges and benefits of formal HVAC education. A significant portion of the discussion focuses on what to look for when evaluating trade schools. The guests emphasize that the investment in laboratory equipment and facilities often reflects the school's commitment to the program - you can tell immediately upon walking into a lab whether the institution truly prioritizes HVAC education. They stress the importance of accreditation, particularly from organizations like HVAC Excellence, which provides regular oversight and ensures schools meet industry standards. The conversation reveals that accreditation isn't just about having a certificate on the wall; it represents a school's willingness to submit to external scrutiny and maintain educational quality. The discussion also addresses the critical balance between theoretical knowledge and practical application. All three speakers agree that the most valuable trade school experiences combine classroom learning with real-world field exposure through partnerships with local contractors, apprenticeship programs, or internship opportunities. They emphasize that instructor quality matters more than having the latest equipment - a humble, field-experienced teacher who can adapt to different student skill levels and learning styles proves far more valuable than someone with extensive theoretical knowledge but limited practical experience. Topics Covered School Evaluation Criteria Laboratory equipment quality and investment levels Accreditation importance (particularly HVAC Excellence) Modern tools vs. traditional equipment balance Manufacturer partnerships and industry connections Instructor Qualifications Field experience vs. teaching credentials Importance of humility and adaptability Managing diverse skill levels in the classroom Storytelling and practical application methods Program Length and Structure Comparison of certificate programs vs. associate degrees Benefits of two-year programs for comprehensive learning Integration of on-the-job training and apprenticeships Realistic expectations for different program lengths Hands-On Learning Importance of repetition and practical experience Managing consumable materials and budget constraints Real-world equipment exposure vs. lab simulations Peer mentoring and collaborative learning approaches Student Readiness and Expectations Managing diverse student backgrounds and skill levels Realistic employer expectations for graduates The value of combining school with field experience Personal responsibility in education and continuous learning Industry Connections Importance of school-contractor partnerships Field trip opportunities and manufacturer relationships Bridging the gap between classroom and real-world application The role of apprenticeships in comprehensive training   Have a question that you want us to answer on the podcast? Submit your questions at https://www.speakpipe.com/hvacschool. Purchase your tickets or learn more about the 7th Annual HVACR Training Symposium at https://hvacrschool.com/symposium. Subscribe to our podcast on your iPhone or Android. Subscribe to our YouTube channel. Check out our handy calculators here or on the HVAC School Mobile App for Apple and Android

Explore the collaborative efforts at UAB Medicine that make National Accreditation Program for Rectal Cancer (NAPRC) accreditation successful. Robert Hollis, M.D., MSPH, and Ridley Brown, BSN, RN, explain how teamwork among surgeons, oncologists, and nurses streamlines patient navigation and care, ensuring that every aspect of a patient's journey is coordinated and efficient.

Crime is down 28% in Cape Coral, and in this episode of the Cape CopCast 'Chief's Chat,' we're breaking down exactly how it happened. Despite our growing population and increasing calls for service, we've achieved remarkable reductions across both violent and property crime categories while maintaining solvability rates well above national averages.What's our secret? Chief Anthony Sizemore says it's right there in our mission statement: "Partnering with the community to ensure the highest level of safety for all." This isn't just aspirational language—it's a practical approach that yields measurable results. When community members lock their doors, report suspicious activity, and maintain open lines of communication with officers, we create a foundation for success. Combine that with strategic deployment, advanced technology, and dedicated personnel who genuinely care about this city, and you've got a winning formula.We're particularly proud of our recent CALEA assessment—the gold standard in law enforcement accreditation that we've maintained since 1989. Assessors came to the department and conducted an exhaustive evaluation of our policies, procedures, and practices, from use of force guidelines to hiring practices that reflect our community's diversity. The result? The most successful evaluation in our department's history, with assessors recommending us as a national model in several areas. This recognition validates the significant innovations we've implemented over the past five years and confirms we're not just meeting standards—we're setting them.Looking ahead, we're expanding our ranks to keep pace with Cape Coral's growth, creating promotional opportunities from top to bottom within our organization. This combination of proven success, external validation, and internal development has created tremendous momentum. Have questions about our approach to community safety? Reach out—partnership is what makes this work, and we're just getting started.

In this episode of the EMS One-Stop podcast, host Rob Lawrence climbs back onto his soapbox to discuss two topics that directly impact on every EMS agency in America — the CAAS Ground Vehicle Standards (GVS) 4.0 and the simple, inexpensive steps we can take to stop ambulance theft. Joining Rob is longtime EMS leader and current CAAS GVS Administrator Mark Postma, who walks us through the origins of the standards, their national adoption and what's new in the latest update. From ambulance remounting, to structural safety testing, Mark explains how GVS 4.0 has evolved to keep pace with manufacturing realities, supply chain delays and operational needs. The conversation then shifts to a shared passion for protecting fleet assets. Rob and Mark dissect the shockingly frequent problem of ambulance theft and how a $200 automatic immobilization device can prevent a $250,000 vehicle from disappearing — without relying on crews to remember to lock it. Additional resources: CAAS GVS V4.0 – Ground Vehicle Standard Commission on Accreditation of Ambulance Services (CAAS) – The New Standard in Mobile Healthcare Ambulance thefts in the U.S. surge: Over 40 stolen rigs in 18 months 6 ways to safety-proof your EMS fleet Memorable quotes "It's no good going to City Council or to your board of directors on day 365 and saying, ‘I need a new truck for New Year day one' — that's not going to happen." — Rob Lawrence "The ground vehicle standard has become the standard that most vehicles are being built to and that state EMS officials are using." — Mark Postma "We spend a lot of time thinking about where things go in the box … add one more thing to your checklist: can the vehicle indeed be immobilized?" — Rob Lawrence "There's just no reason why ambulances are being stolen with the current technology that's out there." — Mark Postma Episode timeline 00:45 – Rob introduces the topic: GVS 4.0 and ambulance theft concerns 01:34 – Mark introduction and CAAS GVS role 04:11 – How the CAAS standards were developed and adopted by 35-plus states 06:09 – Comparing CAAS GVS to NFPA ambulance standards 06:48 – The rise of remounting, especially during COVID supply shortages 10:26 – Discussion of ongoing vehicle delivery delays and need for replacement planning 15:04 – What's new in GVS 4.0 — major changes and safety structure updates 19:38 – Ambulance theft statistics and the GVS anti-theft requirement 22:28 – Automatic immobilization and why manual systems fail 23:57 – Mark shares success story: zero thefts since installing devices 26:17 – Exceptions in standards and why state inspectors must enforce anti-theft 27:42 – Final thoughts on making anti-theft part of fleet planning Enjoying the show? Email editor@ems1.com to share feedback and suggest future guests. 

Office-based anesthesia (OBA) is no longer the “wild west” of healthcare. It's a thriving, highly specialized branch of anesthesia practice that's changing the way patients experience surgery. In this episode, Lynn and Garry take you inside the rapidly growing world of OBA, where 10 million procedures a year are now performed outside hospitals and ambulatory surgery centers. They explore why patients and providers are embracing this setting, the evolving safety standards, and the anesthetic techniques that make it work. Here's some of what you'll hear in this episode:

Navigating Vaccine Hesitancy in Pediatrics Evaluation and Credit:   Navigating Vaccine Hesitancy in Pediatrics   Evaluation and Credit:  https://www.surveymonkey.com/r/medchat81 Target AudienceThis activity is targeted toward primary care physicians and advanced providers. Statement of Need Despite the availability of safe and effective vaccines, pediatricians and clinicians continue to encounter significant vaccine hesitancy among caregivers, which can lead to suboptimal immunization rates and increased risk of preventable diseases. This podcast will provide key information for providers on the causes of vaccine hesitancy and how to address with parents. In that it is a podcast, it will be a discussion with the guest and moderator. Objectives Define pediatric vaccine hesitancy and describe its impact on public health. Discuss key factors that contribute to vaccine hesitancy. Describe effective communication strategies to address parental concerns to improve vaccine confidence in pediatric care. ModeratorMark McDonald, M.D., MHA, CPE System Vice President Pediatric Medical Affairs Medical Director, Norton Children's Louisville, Kentucky SpeakerKristina Bryant, M.D. Pediatric Infectious Diseases Physician Norton Children's Infectious Diseases Chair, Norton Children's Hospital Infection Control Associate Fellowship Director Professor UofL School of Medicine Louisville, Kentucky Planner and Moderator Disclosures  The planners and moderator of this activity do not have any relevant financial relationships with ineligible companies to disclose. Speaker DisclosureThe speaker, Kristina Bryant, M.D. discloses relevant financial relationship with Sanofi as an investigator. She had relationships with Gilead, Enanta Pharmaceuticals and Pfizer as an investigator. These relationships have ended.  All relevant financial relationships have been successfully mitigated. Commercial Support  There was no commercial support for this activity.  GrantThis episode is supported by a grant from the Kentucky Medical Association's ‘Small STEPS, Big Impact' campaign, a two-year initiative that encourages patients to achieve long-term success through taking simple steps that can add up to make a big impact on their health. The campaign focuses on five key areas (screenings, tobacco use, exercise & nutrition, physician visits and stress) and offers straightforward strategies and support for patients. It is a partnership between the KMA and its charitable arm, the Kentucky Foundation for Medical, made possible by a grant from the Kentucky Department for Public Health. For more information, visit SmallSTEPSKy.org.     Physician Credits Accreditation Norton Healthcare is accredited by the Kentucky Medical Association to provide continuing medical education for physicians. Designation Norton Healthcare designates this enduring material for a maximum of .75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Nursing CreditsNorton Healthcare Institute for Education and Development is approved as a provider of nursing continuing professional development by the South Carolina Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation. This continuing professional development activity has been approved for 0.75 ANCC CE contact hours. In order for nursing participants to obtain credits, they must claim attendance by attesting to the number of hours in attendance.   For more information related to nursing credits, contact Sally Sturgeon, DNP, RN, SANE-A, AFN-BC at (502) 446-5889 or sally.sturgeon@nortonhealthcare.org. Social Worker CreditsThe National Association of Social Workers, Kentucky Chapter (NASW-KY), is an approved provider for social work credits through the Kentucky Board of Social Work. This activity will provide 1.0 hours of required continuing education units. NASWKY # 0630/25.   Resources for Additional Study/References A Review of the Resurgence of Measles, a Vaccine-Preventable Disease, as Current Concerns Contrast with Past Hopes for Measles Elimination https://pubmed.ncbi.nlm.nih.gov/38525549/ A Structural Lens Approach to Vaccine Hesitancy and Identity https://pubmed.ncbi.nlm.nih.gov/36841595/ SmallSTEPSKy.org   Date of Original Release | Aug. 2025; Information is current as of the time of recording.  Course Termination Date | Aug. 2027 Contact Information | Center for Continuing Medical EducationNavigating Vaccine Hesitancy in Pediatrics; (502) 446-5955 or cme@nortonhealthcare.org   Also listen to Norton Healthcare's podcast Stronger After Stroke. This podcast, produced by the Norton Neuroscience Institute, discusses difficult topics, answers frequently asked questions and provides survivor stories that provide hope.   Norton Healthcare, a not for profit health care system, is a leader in serving adult and pediatric patients throughout Greater Louisville, Southern Indiana, the commonwealth of Kentucky and beyond. More information about Norton Healthcare is available at NortonHealthcare.com.  

Applying to PA school without checking ARC-PA status? Not a good idea. In this episode, we're making accreditation easy to understand so you can apply confidently—and avoid surprises down the road.This can change everything for you and your PA School Application: VIP Days

“We're really using these in many, many types of malignancies. But you can see this class of drug, these monoclonal antibodies, the small molecule inhibitors, being used in colorectal cancer, ovarian cancer, renal cell carcinoma, brain cancers, hepatocellular, non-small cell lung cancer, gynecologic malignancies, so lots of different types of cancers where we're seeing these drugs used,” Danielle Roman, PharmD, BCOP, manager of clinical pharmacy services at the Allegheny Health Network Cancer Institute in Pittsburgh, PA, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a conversation about the vascular endothelial growth factor (VEGF) inhibitor drug class. Music Credit: “Fireflies and Stardust” by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0  Earn 0.5 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by August 8, 2026. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learner will report an increase in knowledge related to the use of VEGF inhibitors in the treatment of cancer. Episode Notes  Complete this evaluation for free NCPD.  ONS Podcast™ episodes: Pharmacology 101 series Episode 303: Cancer Symptom Management Basics: Ocular Toxicities Episode 244: Cancer Symptom Management Basics: Cardiovascular Complications Episode 196: Oncologic Emergencies 101: Bleeding and Thrombosis Episode 161: Administer Bevacizumab Infusions With Confidence ONS Voice articles: Manage Afatinib's Adverse Events to Keep Patients on Treatment Oncology Drug Reference Sheet: Cabozantinib Oncology Drug Reference Sheet: Fruquintinib Patient Education Needs With Pazopanib Therapy for Soft Tissue Sarcoma ONS books: Chemotherapy and Immunotherapy Guidelines and Recommendations for Practice (second edition) Clinical Guide to Antineoplastic Therapy: A Chemotherapy Handbook (fourth edition) Safe Handling of Hazardous Drugs (fourth edition) ONS courses: Safe Handling Basics Clinical Journal of Oncology Nursing article: Safety and Adverse Event Management of VEGFR-TKIs in Patients With Metastatic Renal Cell Carcinoma Oral Anticancer Medication Care Compass: Resources for Interprofessional Navigation ONS Oral Anticancer Medication Learning Library ONS Oral Anticancer Medication Toolkit IV Cancer Treatment Education Sheets Oral Chemotherapy Education Sheets To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode “Cancer cells are known to secrete factors that cause the formation of new blood vessels, and tumors need blood vessels to supply themselves with nutrients so that they can grow and metastasize. A lot of tumors overexpress these factors, so they had more of this ability to create new blood vessels. You may hear that term somewhere neo vascularization. … And also these factors can increase the permeability of blood vessels, so making them kind of leaky blood vessels. … So the thought behind it is being able to block the ability for this new blood vessel formation and to decrease that leakiness or permeability of those blood vessels.” TS 2:07 “These are drugs that are tyrosine kinase inhibitors. These are oral, small molecule drugs that are acting intracellular, so they are working within the cell to bind and prevent that downstream signaling of producing more blood vessels. So we have a number of small molecule drugs that fall into this class. Many of them target multiple types of receptors, VEGF being included, but also a lot of these drugs have other targets.” TS 7:58 “I would really say, number one, something that we very commonly see with this drug class is hypertension. Giving you an example of bevacizumab—If we look at any grade hypertension, this can be up to 67% of patients, so very common toxicity really spanning all of these agents. So something that we need to be monitoring closely for.” TS 13:24 “With that impaired wound healing, keeping that in mind, as we are planning for this agent, for patients and even sometimes with the minor surgical procedures, maybe a need for a short hold, and even for something like a catheter placement. I know and some of the providers I work with have a preference for holding for a short period of time around that as well.” TS 20:15 “I think one big area, and we've seen some of this just recently, and particularly in the hepatocellular setting, we're seeing combinations of using the VEGF inhibitor class with immunotherapy. And so I think we're going to continue to see that evolve. Even hearing about some bispecific antibodies that are in development, where they are targeting VEGF as well as PD-L1, so getting the immunotherapy and VEGF effects.” TS 24:44

“Colorectal cancer treatment is not just about eliminating a disease. It's about preserving life quality and empowering patients through every phase. So I think nurses are really at the forefront that we can do that in the oncology nursing space. So from early detection to survivorship, the journey is deeply personal. Precision medicine, compassionate care, and informed decision-making are reshaping outcomes. Treatment's just not about protocols. It's about people,” ONS member Kris Mathey, DNP, APRN-CNP, AOCNP®, gastrointestinal medical oncology nurse practitioner at The James Cancer Hospital of The Ohio State University Wexner Medical Center in Columbus, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a conversation about colorectal cancer treatment.  Music Credit: “Fireflies and Stardust” by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0  Earn 1.0 contact hour of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by August 1, 2026. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learner will report an increase in knowledge related to the treatment of colorectal cancer. Episode Notes  Complete this evaluation for free NCPD. ONS Podcast™ episodes: Episode 370: Colorectal Cancer Screening, Early Detection, and Disparities Episode 153: Metastatic Colorectal Cancer Has More Treatment Options Than Ever Before ONS Voice articles: Colorectal Cancer Prevention, Screening, Treatment, and Survivorship Recommendations Genetic Disorder Reference Sheet: Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer) How Liquid Biopsies Are Used in Cancer Treatment Selection Oncology Drug Reference Sheet: 5-Fluorouracil Oncology Drug Reference Sheet: Oxaliplatin What Is a Liquid Biopsy? Clinical Journal of Oncology Nursing article: Colorectal Cancer in Young Adults: Considerations for Oncology Nurses Oncology Nursing Forum article: Neurotoxic Side Effects Early in the Oxaliplatin Treatment Period in Patients With Colorectal Cancer ONS Colorectal Cancer Learning Library ONS Biomarker Database (filtered by colorectal cancer) ONS Peripheral Neuropathy Symptom Interventions American Cancer Society colorectal cancer resources CancerCare Colorectal Cancer Alliance Colorectal Cancer Resource and Action Network Fight Colorectal Cancer National Comprehensive Cancer Network To discuss the information in this episode with other oncology nurses, visit the ONS Communities.  To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode “Colorectal cancer has several different types, but there is one that dominates the landscape, and that is adenocarcinoma. So I think most of us have heard that. It's fairly common, and it accounts for about 95% of all colorectal cancers. It begins in the glandular cells lining the colon or rectum and often develops from polyps, in particular adenomatous polyps.” TS 1:41 “One of the biomarkers that we'll most commonly hear about is KRAS or NRAS mutations. This indicates tumor genetics, and these mutations suggest resistance to our EGFR inhibitors such as cetuximab. BRAF mutation or V600E is a more aggressive tumor subtype, and those may respond to our BRAF targeted therapy. … And then our MSI-high or MMR-deficient—microsatellite instability or mismatch repair deficiency—that really predicts an immunotherapy response and may indicate Lynch syndrome, which is a huge genetic component that takes a whole other level of counseling and genetic testing with our patients as well.” TS 6:02 “Polypectomy or a local excision—that removes our small tumors or polyps during that colonoscopy. And that's what's used for those stage 0 or early stage I cancers. A colectomy removes part or all of the colon. This may be open or laparoscopic. It can include a hemicolectomy, a segmental resection, or a total colectomy, so where you take out the entire part of the colon. A proctectomy removes part or all of the rectum. This may include a low anterior resection, also known as an LAR … or an abdominal perineal resection, which is an APR. … Colostomy or ileostomy—that diverts the stool to an external bag via stoma. Sometimes this is temporary or permanent depending on the type of surgery.” TS 14:11 “We'll have our patients say, ‘Hey, I want immunotherapy therapy. I see commercials on it that it works so well.' We have to make sure that these patients are good candidates for it, also that we're treating them adequately. We need to make sure that they have those biomarkers, so as I mentioned, the MSI-high or MMR tumors. Our MSS-stable tumors—they may benefit from newer combinations or clinical trials. Metastatic disease—immunotherapy may be used alone or with other treatments. And then in the neoadjuvant setting, some trials are really showing promising results using immunotherapy prior to surgery.” TS 25:38 “Antibody-drug conjugates are really an exciting frontier in all cancer treatments as well as colorectal cancer treatment. This is used mainly for patients with advanced or treatment-resistant disease, and these therapies combine the targeted power of monoclonal antibodies with the cell-killing ability of potent chemotherapy agents. They're still on the horizon for the most part in colorectal cancer. However, there is only one approved antibody-drug conjugate, or ADC, at this time, and that's trastuzumab deruxtecan, or Enhertu. That's approved for any solid tumor, such as colorectal cancer with HER2 IHC 3+. So again, looking back at that pathology in those markers, making sure that you have that HER2 mutation and that IHC.” TS 35:00 “There are a few myths going around about colorectal cancer treatment that can lead to confusion or even delayed care. One myth is only older men get colorectal cancer. As you heard me talk in my previous podcast on screening, unfortunately, this isn't necessarily true. Colorectal cancer affects both men and women and our cases in the younger population are rising. So our screening guidelines have changed to age 45 because we are seeing it in the younger population.” TS 45:54

Accreditation affects everything from financial aid to institutional viability—but many board members don't realize how directly they're accountable. In this episode, AGB's Natalie Boehm talks with AGB Consultant John Cavanaugh about what every board should know: why accreditation matters, how it connects to fiduciary duties, and what questions boards should be asking. Opinions expressed in AGB podcasts are those of the speakers and not necessarily those of the organizations that employ them or of AGB.

#RonnieLo #habitcoach #drkimberleylinert #incrediblelifecreatorpodcast RonnieLo Habit Coach (Ronnie Loaiza - pronounced "Low-eye-zuh") is a Certified Habit Coach, Master Certified Professional Life Coach, and Certified Personal Trainer dedicated to helping people realize their desires and goals, one tiny step a time – that form into driving, naturally sustainable habits.Unlike quick fixes and temporary hacks that lead to burnout, Ronnie focuses on the science-backed process of creating habits- instead of forced self-discipline or constantly summing up your willpower – as that becomes exhausting.Combining her years of coaching experience with her deep understanding of behavioral science, Ronnie guides each client from identifying their true goal and the reasoning behind that goal, to taking practical action.You then convert those tiny actions into effective habits, which drive you to your goal.Her approach reprograms your 'Habitual Way of Thinking,' making positive habits a natural part of your daily routine, seamlessly aligned with your identity.Ronnie's coaching is all about support, accountability, and celebrating progress. Her pragmatic, science-based methods ensure that the habits you develop are sustainable and truly impactful.When she's not coaching, Ronnie loves dancing, watching movies, strength training, traveling, and spending time with her husband and cats.((Notes if host wants them for during or at the end of interview:))Learn more about Ronnie in 'About' at www.ronnielolifecoach.comAlso see her method of tailored coaching and how you can form habits that change your life!Master Certified Professional Life Coach (ICF Accredited)Certified Habit Coach (National Board for Health & Wellness Coaches)Certified Personal Trainer with Accreditation in Corrective Exercise, Behavior Change, Senior Fitness, Women's Fitness, Mental Toughness, and Nutrition.Contact Ronnie Loaiza:https://www.linkedin.com/in/ronnielolifecoachhttps://ronnielolifecoach.comIGRonnie Carol Loaiza (@ronnielolifecoach) • Instagram photos and videoshttps://www.instagram.com/ronnielolifecoach/Dr. Kimberley LinertSpeaker, Author, Broadcaster, Mentor, Trainer, Behavioral OptometristEvent Planners- I am available to speak at your event. Here is my media kit: https://brucemerrinscelebrityspeakers.com/portfolio/dr-kimberley-linert/To book Dr. Linert on your podcast, television show, conference, corporate training or as an expert guest please email her at incrediblelifepodcast@gmail.com or Contact Bruce Merrin at Bruce Merrin's Celebrity Speakers at merrinpr@gmail.com702.256.9199Host of the Podcast Series: Incredible Life Creator PodcastAvailable on...Apple: https://podcasts.apple.com/us/podcast/incredible-life-creator-with-dr-kimberley-linert/id1472641267Spotify: https://open.spotify.com/show/6DZE3EoHfhgcmSkxY1CvKf?si=ebe71549e7474663 and on 9 other podcast platformsAuthor of Book: "Visualizing Happiness in Every Area of Your Life"Get on Amazon:https://amzn.to/4cmTOMwWebsite: https://www.DrKimberleyLinert.comPlease subscribe, share & LISTEN! Thanks. incrediblelifepodcast@gmail.comSocial Media LinksLinkedIn: https://www.linkedin.com/in/dr-kimberley-linert-incredible-life-creator/Facebook: https://www.facebook.com/kimberley.linert/The Great Discovery eLearning Platform: https://thegreatdiscovery.com/kimberley

In this episode of The P.A.S. Report, Professor Nick Giordano is joined by Adam Kissel, author of Slacking: A Guide to Ivy League Miseducation and visiting fellow for higher education reform at The Heritage Foundation. Kissel exposes the rot inside elite institutions, from Columbia University's descent into radicalism to the broader crisis of academic decline and student activism replacing scholarship. He explains why the name on a diploma too often outweighs the quality of education received, how taxpayer dollars are fueling the problem, and what states like Florida are doing to restore civic knowledge and classical learning. This conversation is essential listening for anyone concerned about the future of American higher education. Episode Highlights: How the Ivy League became more about prestige than academic excellence Why radicalism and disruptions threaten free speech and civic discourse What states can do to bring back classical education and real accountability

求职或向他人介绍自己时，常常需要介绍自己的学习和工作经历。单词 “qualification” 和 “certification” 都可以表示 “学历，资质”，但它们之间有什么不同？为什么具有类似含义的单词 “accreditation” 则不能用于描述 “个人的学历、资格证书”？听节目，跟主持人 Beth 和步理一起辨析四个可以表示 “资格，资质” 的单词。

InTouch with Terri is brought to you by Podium: Podium is a platform providing AI-powered communication solutions for lead conversion and patient retention. In Touch with Terri listeners get their first month of Podium free CLICK HERE. Be sure to tune into the full conversation to uncover detailed insights into transforming your aesthetic practice by leveraging patient retention strategies. Subscribe for more episodes and stay informed about the latest developments and strategies in the industry  Get InTouch with Terri! Terri Ross Website: Click Here Terri Ross Patreon: Business and Sales Mentorship 4S Summit Info: For more details, look up 4S Summit to understand its role in providing strategic business consulting in the aesthetics industry https://4ssummit.com/ Terri Ross is a renowned expert in the aesthetic industry, specializing in sales training, strategic growth consulting, and business transformation. As an accomplished author and international speaker, Terri has dedicated over two decades to elevating businesses in the aesthetic field with a ground-up approach focused on sustainability, profitability, and scalability. Her experience is rooted in working with Fortune 500 companies like Medicis and Zeltique, where she developed a deep understanding of market dynamics and strategic sales methodologies. About the Guest: Thomas Terranova is the CEO of Quad A, a globally recognized accreditation body known for its dedication to surgical safety. He is an attorney by training, specializing in international mergers and acquisitions, with previous experience advising multinational corporations using data analytics. At Quad A, Thomas steers the organization's strategic direction, ensuring the adherence to quality standards across surgical and non-surgical medical aesthetic practices. Under his leadership, Quad A is pioneering a new accreditation initiative for non-surgical medical aesthetics to enhance patient safety and facility standards worldwide. Quad A Website: quada.org Episode Summary: Welcome to this engaging episode of "In Touch with Terri," where we explore the dynamic world of accreditation in the booming aesthetics industry. Host Terri Ross converses with Thomas Terranova, CEO of Quad A, about an exciting and crucial initiative to introduce a global accreditation framework for non-surgical medical aesthetic practices, such as med spas. As the industry surges ahead with rapid growth, this initiative aims to bridge the current regulatory gap, providing a structured and formal oversight mechanism that has long been absent in non-surgical environments. In this revealing discussion, Terri and Thomas delve into the pressing safety gaps in the medical aesthetics sector. With an understanding that current growth has outpaced both regulations and common best practices, Thomas outlines the steps Quad A is taking to standardize safety, excellence, and consistency. The pair highlight the potential impacts of this initiative on both practitioners—ensuring legitimate, safe operations—and patients who will gain increased confidence in the services they receive. Attentive listeners will learn about the core pillars of this new accreditation framework, the challenges faced during its development, and its anticipated positive repercussions on the global stage. Key Takeaways: The medical aesthetics industry is experiencing rapid growth but lacks adequate regulation, particularly in non-surgical environments such as med spas. Quad A, under the leadership of Thomas Terranova, is leading a global initiative to develop an accreditation framework for non-surgical medical aesthetic practices. The accreditation aims to ensure patient safety, enhance facility standards, and instill greater confidence in aesthetic treatments. The initiative includes comprehensive documentation, rigorous staff training, and the adoption of standard operating procedures to minimize risks. Educating patients and making safety considerations front-and-center are key strategies for improving consumer trust and industry standards. Notable Quotes: "If you're a well-intentioned practitioner, whatever we're talking about are nothing to be afraid of. The only people that should be afraid are the people who don't want to do things right." "Product is a big one. And again, with supply chain, the way it is... that's a huge concern." "It's a choice to do things the right way. It's a choice to do it in a way that's safe." "We're bringing this back to medicine. We're talking about making sure the products are valid, properly maintained, and that the staff is well-trained."

Higher education leaders are facing the most sweeping set of federal regulatory and funding changes in over a decade. In this Washington Update episode of the Changing Higher Ed® podcast, Dr. Drumm McNaughton welcomes back frequent guest Tom Netting, president of TEN Government Strategies, to discuss the July 2025 budget reconciliation bill—federal legislation that significantly alters student loans, Pell Grants, institutional accountability, and the rules governing program eligibility. While not a formal reauthorization of the Higher Education Act, the bill introduces statutory earnings-based accountability for degree programs, lifetime loan caps, professional judgment changes, and new eligibility requirements for short-term Pell programs. Netting also discusses concurrent developments in accreditation and distance education oversight, including the rise of a new accreditor in Florida and its potential implications for NC-SARA and federal triad stability. This episode is a must-listen for presidents, trustees, CFOs, and compliance officers preparing for upcoming reporting deadlines, new negotiated rulemaking cycles, and long-term institutional planning under new federal constraints. Topics Covered How the July 2025 reconciliation bill rewrites federal student aid and accountability rules What the new earnings-based accountability measure means for degree programs Pell Grant expansion for short-term workforce programs and the required outcomes thresholds The elimination of Grad PLUS loans and new lifetime borrowing caps for students and families Changes to professional judgment authority and how institutions can apply it by cohort New 90/10 revenue guidance and how it affects distance education classifications Delayed implementation of Borrower Defense and Closed School Discharge regulations The emergence of Florida's state-based accreditor and its expected NACIQI review Why NC-SARA recognition may be impacted by nontraditional accreditation The likelihood of a second reconciliation bill or technical corrections package Three Key Takeaways for Leadership Institutional leaders must prepare now for dual accountability frameworks and new reporting obligations. Expanded professional judgment offers new flexibility but must be applied with consistency and clear documentation. Accreditation and state authorization pathways are shifting—compliance teams must monitor evolving standards across federal and state lines. This episode provides critical insights for leaders navigating a changing regulatory environment, with practical implications for finance, compliance, and academic planning. Recommended For: Presidents, trustees, chief financial officers, compliance officers, and accreditation liaisons responsible for institutional strategy and Title IV eligibility. Read the transcript:  https://changinghighered.com/washington-update-july-2025-reconciliation-bill-impact-on-higher-ed/ #HigherEdPolicy #July2025ReconciliationBill #FinancialAidCompliance #FederalLegislation #HigherEducationPodcast  

Episode 252: Most CX maturity assessments ask how you think you're doing. This one demands proof. Erin Wallace, director of client engagement at MyCX from Bain & Company, is helping to lead a fundamental shift in how companies measure CX maturity. Most tools rely on perception-based self-assessments that reward self-promotion over progress. The Customer Experience Roadmap and Accreditation (CXRA) demands verifiable proof—evidence against 55 global, industry-backed standards. It's not always comfortable, but it's often the turning point. Bain's CXRA challenges the internal echo chamber. Erin explains how most assessments rely on surveys sent to a handful of CX insiders, producing a distorted view of reality. The CXRA demands documentation of policies, processes, behaviors, and measurable outcomes such as customer experience metrics, operational KPIs, or business results. It uses outside-in validation to confront that distortion. This isn't academic. It's where things get real. Leaders often push back. Some insist, “We're better than this.” Others admit, “We're not as good as we might think.” That tension is the point. Because CXRA doesn't just assess quality—it measures how consistently CX practices are applied across the business. That's how it exposes the “pockets of brilliance” that never scale, leaving most customers with a fragmented, uneven experience and leadership teams with a false sense of progress. For many leaders, conducting the CXRA offers clarity they've never achieved: a shared fact base, benchmarks of world-class practice, and a clear path forward. It doesn't just reveal what's missing, it builds the conviction to fix it. Guest: Erin Wallace, Director of Client Engagement, Bain & Company Host: Rob Markey, Partner, Bain & Company Give Us Feedback: Help us improve the podcast (feedback link) Key Topics Covered 01:00 – Why perception-based CX tools fall short 02:20 – What defines a successful evidence-based assessment 03:10 – The challenge with identifying “pockets of brilliance” 04:15 – How companies respond to uncomfortable truths 05:40 – Aligning leaders around what “good” really looks like 06:55 – Using 55 global standards to benchmark performance 08:10 – What Bain's CX Roadmap and Accreditation assesses 09:30 – What Erin learned at the X4 2025 Conference in Salt Lake City Time-Stamped Notable Quotes [5:00] “MyCX℠ is  a tool anyone in the industry can use, whether you're a strategic advisor, a technology implementer, or a CX practitioner. These should be things we agree on in terms of the standard of excellence for culture, capabilities, and execution.” [6:00]  “Most maturity assessments—tools to understand where you are and how you're doing with CX—are survey-based. They're perception-based. We send [them] out to a couple hundred people in the company, see what they think, and how they think they're doing with CX. You usually get back a pretty inactionable result. What's different about MyCX Roadmap and Accreditation, which is based on these global standards, is that it's an evidence-based, outside-in assessment.” [7:00] “It's an opportunity to dig in and have a conversation. And to evaluate the perception with the policy against results.” [8:00] “We look at quality, coverage, and consistency of application across the business. There could very well be a spotlight—like pockets of excellence—that are not applied across the organization in a meaningful way.” “[9:00] “What does good look like, and is that really what we aspire to accomplish? And then what will it take to get there? Because oftentimes, everyone has a different opinion of what is ‘good.' And do we really want to get there? This helps [organizations] break through and get that bigger investment unlock that's required to lead.” Learn more about Bain & Company's CX Roadmap and Accreditation process: https://www.bain.com/consulting-services/customer-strategy-and-marketing/customer-experience-transformation/mycx/ Learn more about the Global CX Standards: https://www.netpromotersystem.com/resources/cx-standards/

The news of Texas covered today includes:Our Lone Star story of the day: The first called session of the 89th Legislature is underway in Austin as of Noon today. Congressional redistricting takes the national spotlight but there is a long list of highly important items on the Governor's call – it is probably too much for one 30-day session.Speaker of the House Burrows, founder of the Bureaucrat Coalition, named a special committee for redistricting. On the surface it looks heavily tilted to Republicans until one realizes that the 3-vote GOP majority on the committee is offset by Burrows appointment of three of the most liberal RINOs to the committee: Geren, Hunter, and Guillen.Our Lone Star story of the day is sponsored by Allied Compliance Services providing the best service in DOT, business and personal drug and alcohol testing since 1995.Busting two common myths about Property Taxes perpetuated by politicians and  local media.Records show DEI standards used to pressure law schools to adopt racist practices. Texas law school deans (including at Texas Tech) want to deep DEI-infused ABA accreditation!Republican launches TX34 House bid in key Rio Grande Valley swing district GOP aims to flip in 2026 midterms – Eric Flores.Listen on the radio, or station stream, at 5pm Central. Click for our radio and streaming affiliates.www.PrattonTexas.com

Too often, distance learning gets dismissed as fragmented or disjointed, seen as a patchwork of tech tools rather than a cohesive educational system. Teachers feel pulled in too many directions, and programs struggle to sustain impact beyond the novelty of going virtual.In this episode, Dr. Chris Harrington - leader of the EmpowerEd Research Institute, AccredVEd, and Digital Learning Works - shares how real transformation happens when virtual education is approached as a system. From curriculum to leadership to parent engagement, Chris lays out what it means to create a student-centered, coherent virtual learning ecosystem. He introduces specialized accreditation processes, discusses how to build systems around people - not tech - and shares inspiring stories from the field, including how one virtual program helped a struggling student graduate against the odds.If you're building - or rebuilding - a distance learning program, listen in for insights on:Why cohesion is the key to long-term success in virtual education.How to lead systems change with clarity, equity, and community buy-in.The power of specialized accreditation to elevate—not just evaluate—program quality.What it really means to put relationships at the center of digital learning.Episode Links:Digital Learning WORKSEmpowerEd Research InstituteAccredVEdHost Links:Discover more virtual learning opportunities and resources at CILC.org with Tami Moehring and Allyson Mitchell.Seth Fleischauer's Banyan Global Learning provides meaningful global learning experiences that prepare students across the globe for success in an interconnected world.

“The proteasome itself, it really helps us unfold or get rid of misfolded proteins or degradations of different cells. We used to have garbage disposals in our sinks, and we used to put food product in there. If your garbage disposal is clogged, then everything backs up. So that's kind of what's really going on in the cell itself, is that I'm building up these unnecessary proteins that we should be getting rid of, and it actually causes apoptosis or cell death,” ONS member Daniel Verina, DNP, RN, ACNP-BC, nurse practitioner for the multiple myeloma program at Mount Sinai Medical Center in New York, NY, told Lenise Taylor, MN, RN, AOCNS®, BMTCN®, oncology clinical specialist at ONS, during a conversation about the proteasome inhibitor drug class. Music Credit: “Fireflies and Stardust” by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0  Earn 0.75 contact hours (including 40 minutes of pharmacotherapeutic content) of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by July 18, 2026. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learner will report an increase in knowledge related to the use of proteasome inhibitors in the treatment of cancer. Episode Notes  Complete this evaluation for free NCPD.  ONS Podcast™ Pharmacology 101 series ONS Voice article: AI Multiple Myeloma Model Predicts Individual Risk, Outcomes, and Genomic Implications ONS books: Chemotherapy and Immunotherapy Guidelines and Recommendations for Practice (second edition) Clinical Guide to Antineoplastic Therapy: A Chemotherapy Handbook (fourth edition) Guide to Cancer Immunotherapy (second edition) Multiple Myeloma: A Textbook for Nurses (third edition) Clinical Journal of Oncology Nursing article: Optimizing Transitions of Care in Multiple Myeloma Immunotherapy: Nurse Roles Oncology Nursing Forum articles: Changes in Health-Related Quality of Life During Multiple Myeloma Treatment: A Qualitative Interview Study Facilitators of Multiple Myeloma Treatment: A Qualitative Study ONS Guidelines™ and Symptom Interventions Adherence to Oral Anticancer Medication Peripheral neuropathy ONS Hematology, Cellular Therapy, and Stem Cell Transplantation Learning Library American Society of Hematology International Myeloma Foundation Leukemia and Lymphoma Society Multiple Myeloma Research Foundation To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode “When we look at the administration, we also want to make sure that we're looking at the blood counts, right? Because proteasome inhibitors are well known for causing thrombocytopenia and neutropenia. So making sure that the patients do meet eligibility for the treatment for that day, and do they have anemia or lower red blood cell counts. You want to make sure that, because of these therapies, that the patient has no symptoms or infections going into each therapy for that day.” TS 10:19 “[Bortezomib], interesting enough, it can cause hypotension, cardiac failure, and sometimes pulmonary edema. Switching that up a little bit, what makes it slightly different, carfilzomib … a lot of times we saw, even in the clinical trial, that there was a lot of hypertension or cardiomyopathies, or arrythmias that we saw with carfilzomib and different dosages that they have indicated from the FDA. So again, monitoring the hypertension … or heart failure.” TS 15:16 “We also want to keep in mind another adverse effect, and especially in myeloma—our patients come in the door already immunocompromised just by the disease state alone. But now I'm giving them therapies that can drop their neutrophil count, so neutropenia and thrombocytopenia, so they are at a higher risk of having serious infections, even including like pneumonia or having outbreaks of herpes zoster or shingles.” TS 16:50 “If the patient has shortness of breath or symptoms, hold the therapy. I think that's one of my biggest messages when it comes to cancer treatments and educating other healthcare providers, or even educating our patients and their caregivers or the care partners with them, is that we need to sometimes hold the therapy for safety.” TS 22:02 “I say keep a log, keep a book. Let me know when the symptoms happen. Are they happening the day of treatment? Are they happening two days later from the treatment? Are they happening a week later from the treatment? And being able to kind of guide which therapy is causing some of these adverse events or side effects alone. So, making them have calendars. When did you take the drug, when did you get your last infusion or your last [subcutaneous] injection? Always talk to your care team, whether it's in the academic center or next to your house in the community.” TS 26:17 “It's us learning how to listen to the patient going forward. We have tasks to do—we all have tasks to do in our lives—but we have to take a breath, be mindful who's in front of us, listen to them first, and then be able to talk to them and care for them upfront and see what the symptoms are. I think that's what we need to do. We have to take a breath in cancer.” TS 39:35

Episode 251: In 2018, Dell set out to do something big: turn customer feedback into a system that could not only provide insights, but help set priorities and run the business. They had the data. They had the intent. But they made a compromise that many organizations settle on: Rather than enforce one unified approach to customer feedback, they allowed each team to build its own. While this helped with initial adoption and change management, it also led to fragmentation—multiple tools, different methods, no shared truth. And it got worse over time. Real progress ultimately would require centralizing what had become scattered. When Dell's Marc Stein appeared on this podcast in 2018 (episode 129), the company had just completed its EMC merger and launched a chief customer office. The ambition: one integrated Net Promoter System to tie sentiment to economics and put the customer at the center of every decision. But good intentions ran into a harsh reality: Every function was listening to customers, but no one was hearing the same thing.  In this episode, Mike Valanzola, Dell's Senior Director of Voice of Customer and NPS Operations, picks up the story. He explains how misaligned tools, siloed ownership, and governance gaps made customer feedback hard to act on. His team didn't want to tear down what existed. Instead, they brought it together. Through consolidation, centralization, shared standards, and stronger governance, they transformed scattered signals into an enterprise-wide system of action. The turning point came with the Customer Experience Roadmap and Accreditation. The CXRA gave Dell a framework to drive internal accountability and rebuild trust in the system. As Mike describes, cross-functional teams now meet weekly to act on shared signals. Tomorrow's goal? Make every employee a promoter and make every signal actionable. Guest: Mike Valanzola, Senior Director, Voice of Customer and NPS Operations, Dell Technologies Host: Rob Markey, Partner, Bain & Company Give us feedback: Customer Confidential Podcast Feedback Send us a note: Contact Rob Time-Stamped Topics 00:01 - Marc Stein's 2018 ambition: a unified CX system 03:50 - Why integration faltered: fragmentation, politics, data overload 06:20 - Mike's mission: centralize tools, enforce governance 10:00 - Transforming custom systems to create shared accountability 13:30 - Early delivery surprises and sentiment gaps 17:10 - Predictive models and operational fixes 21:00 - How Dell built trust in the new NPS engine 27:45 - Weekly action meetings: turning listening into doing 35:30 - Why CXRA certification mattered, internally and externally 40:00 - Reflections on past company decisions Notable Quotes “ We have a robust  partner community that allows us to  expand our scale in terms of the customers that we can  touch. Each and every one of those folks has some things that are important for us to hear.” [8:00]  ”We do—and did—as a company, listen regularly, but we didn't always hear. The reason for that came down to every function across the company, ultimately doing their own listening programs, using their own application, governing how they listened, controlling what they got back, and not sharing it.” [18:00]  ”We had been really in a run-the-business function, really focused on  NPS management, really focused on owning  that measurement for the company. And now, I was proposing a large-scale, end-to-end corporate transformation that was going to require my own team  to think about how we operate, and effectively operate differently.” [28:00] Additional Resources Hear our 2018 podcast with Marc Stein on Dell's original CX ambition, Bringing Net Promoter to Scale Learn more about Bain's MyCX Roadmap & Accreditation

A Testament To Conservative Victory In Tennessee…Eliminating Accreditation Of Colleges That Reject DEI…Property Owners Have To Pay For Removal Of Homeless Encampments???~The Tennessee Conservative's Olivia Lupia on Yaffee LIVECheck out more from Yaffee Here - https://www.wgow.com/2025/05/12/yaffee-live-2/All of the news stories Yaffee & Olivia talk about can be found on TennesseeConservativeNews.com!https://tennesseeconservativenews.com/state/

Republican-led states, spearheaded by Florida Governor Ron DeSantis, are launching a new accreditation body for higher education, aiming to dismantle existing standards deemed 'ideologically biased.' This move seeks to strip colleges of diversity, equity, and inclusion initiatives, replacing robust academic curricula with 'anti-woke' content focused solely on workforce metrics and conservative dogma. It's a transparent ploy to cultivate a less critically thinking populace, benefit dubious institutions like 'Trump University,' and funnel taxpayer money to politically aligned ventures. This attack on comprehensive education prioritizes control and revenue over intellectual development, turning higher learning into an echo chamber for a narrow ideology, ultimately undermining the very fabric of an informed citizenry.News Source:Universities Creating New Accreditation Agency In Some Republican StatesBy Dan Levin and Karah Rucker for Straight Arrow NewsJune 27, 2025

In this episode, Dr. Nathaniel Wilson provides some brief updates and then shares news regarding the recent accreditation of Wilson Academy Online.

Episode 80: Balancing Relief and Risk: Pain Management and Opioid Prescribing in Children and Adolescents   Evaluation and Credit:  https://www.surveymonkey.com/r/medchat80 Target Audience             This activity is targeted toward primary care physicians and advanced providers. Statement of Need This podcast will address effective pain management in adolescents and teens and the utilization of opioids and risk reduction. Pediatricians may not have up-to-date knowledge and skills to effectively balance pain management with opioid safety in children and adolescents. Current practice often reflects underuse of multimodal pain strategies, inconsistent application of opioid prescribing guidelines, and limited screening for substance use disorders (SUDs) in youth. This educational activity addresses the gap between current and optimal practice by enhancing pediatricians' competence in evidence-based opioid prescribing and their performance in implementing risk mitigation strategies in clinical settings. Objectives Describe evidence-based guidelines for prescribing opioids in a manner that optimizes both pain treatment and safety for children and adolescents (“youth”). Discuss evidence-based strategies for the prevention, screening, and treatment for substance use disorders in youth. ModeratorMark McDonald, M.D., MHA, CPE System Vice President Pediatric Medical Affairs Medical Director, Norton Children's Louisville, Kentucky SpeakerScott E. Hadland, M.D., MPH, MS Associate Professor of Pediatrics Chief, Division of Adolescent and Young Adult Medicin Mass General Hospital for Children / Harvard Medical School Boston, MA Moderator, Speaker and Planner Disclosures  The planners, moderator and speaker of this activity do not have any relevant financial relationships with ineligible companies to disclose.   Commercial Support  There was no commercial support for this activity.    Physician Credits Accreditation Norton Healthcare is accredited by the Kentucky Medical Association to provide continuing medical education for physicians. Designation Norton Healthcare designates this enduring material for a maximum of .75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. HB1This program has been approved for .75 HB1 credit hours by the Kentucky Board of Medical Licensure, ID# 037-H.75 NHC3A. Nursing Credits Norton Healthcare Institute for Education and Development is approved as a provider of nursing continuing professional development by the South Carolina Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation. This continuing professional development activity has been approved for 0.75 ANCC CE contact hours.  In order for nursing participants to obtain credits, they must claim attendance by attesting to the number of hours in attendance.  For more information related to nursing credits, contact Sally Sturgeon, DNP, RN, SANE-A, AFN-BC at (502) 446-5889 or sally.sturgeon@nortonhealthcare.org.   Resources for Additional Study/References Screening to Brief Intervention (S2BI) https://nida.nih.gov/s2bi Brief Screener to Tabacco, Alcohol, and other Drugs https://nida.nih.gov/bstad/ Crafft Screening Tools https://crafft.org/ Opioid Prescribing for Acute Pain Management in Children and Adolescents in Outpatient Settings: Clinical Practice Guideline https://publications.aap.org/pediatrics/article/154/5/e2024068752/199482/Opioid-Prescribing-for-Acute-Pain-Management-in?autologincheck=redirected Find Treatment Website https://findtreatment.gov/   Date of Original Release | July 2025; Information is current as of the time of recording. Course Termination Date | July 2028 Contact Information | Center for Continuing Medical Education; (502) 446-5955 or cme@nortonhealthcare.org Also listen to Norton Healthcare's podcast Stronger After Stroke. This podcast, produced by the Norton Neuroscience Institute, discusses difficult topics, answers frequently asked questions and provides survivor stories that provide hope. Norton Healthcare, a not for profit health care system, is a leader in serving adult and pediatric patients throughout Greater Louisville, Southern Indiana, the commonwealth of Kentucky and beyond. More information about Norton Healthcare is available at NortonHealthcare.com.    

https://carnegieclassifications.acenet.edu/The One Big Beautiful Bill is now law, and colleges are facing a wave of new policies with real consequences for students and campuses. Mushtaq Gunja, Jon Fansmith, and Sarah Spreitzer break down what's coming for student loans, Pell Grants, accountability rules, endowment taxes, and more. Plus, a quick look at what's ahead for FY 2026 federal funding and accreditation. Here are some of the links and references from this week's show: Reconciliation Reconciliation Bill Narrowly Passes Congress ACE | July 3, 2025 Summary: One Big Beautiful Bill Act ACE | July 10, 2025 Trump Signed the ‘Big Beautiful Bill.' What's Next? Inside Higher Ed | July 10, 2025 Contains a list of deadlines What the Republicans' New Policy Bill Means for Higher Education The New York Times (sub. req.) | July 3, 2025 8 Million Federal Student Loan Borrowers Will Soon See Interest Restart The New York Times | July 9, 2025 Senate GOP Plots How to Move Trump's $9.4B Clawbacks Request Politico | July 8, 2025 Carnegie Classifications College Scorecard Appropriations White House FY 2026 Budget Proposal Targets Education, Science, and Civil Rights Funding ACE | May 9, 2025 A Review of the President's Fiscal Year 2026 Budget Request for the Department of Education Senate Appropriations Committee | June 3, 2025 Accreditation Reforming Accreditation to Strengthen Higher Education White House | April 23, 2025 Education Department Postpones NACIQI Summer Meeting Inside Higher Ed | July 8, 2025 6 States Partner to Launch New Accreditor Inside Higher Ed | June 26, 2025 U.S. Department of Education Expands Accreditation Options for Colleges and Universities Department of Education | May 1, 2025 Trump Administration Threatens Harvard's Accreditation, Seeks Records on Foreign Students Reuters | July 9, 2025

This Day in Legal History: Second Bank of the United States VetoedOn July 10, 1832, President Andrew Jackson vetoed legislation that would have renewed the charter of the Second Bank of the United States, setting off a fierce political and constitutional conflict known as the “Bank War.” The Bank, originally chartered in 1816, acted as a quasi-governmental financial institution and played a central role in stabilizing the U.S. economy. Jackson, however, saw the Bank as a symbol of entrenched privilege and a threat to democratic values. In his veto message, he argued that the Bank was unconstitutional—even though the Supreme Court had previously upheld its legitimacy in McCulloch v. Maryland (1819)—and that it concentrated too much financial power in the hands of a wealthy elite.Jackson framed his opposition as a defense of the common man against corporate monopoly. His veto marked a dramatic assertion of presidential power, expanding the scope of the executive's role in legislative review. By directly challenging a long-standing institution supported by Congress and the courts, Jackson redefined the balance between branches of government. His veto was also politically strategic, rallying populist support ahead of the 1832 presidential election, which he would go on to win decisively.The fallout was immense: Jackson's administration began withdrawing federal funds from the Bank and redistributing them to selected state banks, derogatorily termed “pet banks.” This redistribution triggered economic instability and helped contribute to the Panic of 1837. Despite intense opposition from figures like Henry Clay and Nicholas Biddle, the Bank's president, Jackson remained steadfast, and the Bank's federal charter ultimately expired in 1836.The legal significance of this event lies in its reimagining of the veto as a political, not merely constitutional, tool. Jackson's interpretation of the Constitution, driven by populist ideals rather than judicial precedent, established a precedent for a more active and independent executive.A federal judge in New Hampshire, Joseph Laplante, is set to hear arguments on whether to block President Donald Trump's executive order restricting birthright citizenship, despite a recent Supreme Court decision limiting the use of nationwide injunctions. The American Civil Liberties Union (ACLU) is asking the court to grant class-action status to a lawsuit aimed at protecting U.S.-born children whose parents are not citizens or lawful permanent residents. If class status is granted, it could enable a nationwide block on the policy through the class action mechanism—something the Supreme Court ruling left open as an exception to its injunction restrictions.Trump's executive order, issued on his first day back in office in January, would deny citizenship to children born in the U.S. unless at least one parent is a citizen or green card holder. The Supreme Court previously narrowed three injunctions against the order, but did not rule on its constitutionality. Opponents argue the order violates the 14th Amendment and contradicts the precedent set in United States v. Wong Kim Ark (1898), which affirmed that birthright citizenship applies regardless of a parent's immigration status.Judge Laplante had already ruled in February that the policy was likely unconstitutional and issued a limited injunction affecting only certain advocacy groups. The ACLU is now urging him to expand this to a broader class of affected families, citing the risk of statelessness or undocumented status for tens of thousands of children. The Justice Department, meanwhile, claims the plaintiffs are too diverse to form a single legal class and that the suit bypasses proper legal procedures.Judge to weigh blocking Trump on birthright citizenship despite Supreme Court ruling | ReutersThe Trump administration escalated its standoff with Harvard University by threatening its accreditation and subpoenaing records related to international students. Federal officials claimed Harvard may have violated anti-discrimination laws by failing to protect Jewish and Israeli students, citing a Title VI investigation by the Department of Health and Human Services. As a result, the Education and Health Departments formally notified Harvard's accrediting body that the university might not meet its standards. However, the accreditor clarified it operates independently and typically allows schools up to four years to come into compliance.Simultaneously, the Department of Homeland Security announced plans to issue subpoenas targeting potential "criminality and misconduct" among student visa holders at Harvard. These actions follow previous federal efforts to block Harvard from admitting international students and to freeze billions in grants, which the university is currently challenging in court. A judge had already halted Trump's proclamation barring foreign students, though the administration is appealing that ruling.Trump accused Harvard of fostering antisemitism and "woke" ideology, while the university insists the administration's actions are politically motivated retaliation infringing on its First Amendment rights. Nearly 6,800 international students—about 27% of Harvard's student body—could be affected if the administration succeeds in stripping the university of its ability to host them. A separate lawsuit seeking to unfreeze $2.5 billion in grants is set to be heard on July 21.Trump administration threatens Harvard's accreditation, seeks records on foreign students | ReutersThe U.S. Department of Agriculture (USDA) announced it will no longer consider a farmer's race or sex when administering many of its key programs, including those related to loans, commodities, and conservation. The decision follows directives from the Trump administration aimed at rolling back diversity, equity, and inclusion (DEI) initiatives across federal agencies. According to the USDA, the shift reflects its belief that past discrimination has been sufficiently addressed and that programs should now focus solely on merit and fairness.The final rule, signed by the USDA's acting General Counsel, states that race- or sex-based criteria will no longer influence program eligibility or funding decisions, though some advantages remain for beginning and military veteran farmers. For decades, the agency had designated certain groups—such as women and farmers of color—as "socially disadvantaged," often creating set-asides or prioritizations for them. This latest move effectively ends that practice.Critics argue the change undermines transparency and accessibility for farmers of color who have historically faced systemic exclusion. Legal scholar Margo Schlanger, formerly involved in USDA civil rights work, said the rule shuts off a vital avenue for ensuring equitable access to federal support. The decision comes despite the fact that only about 4.5% of U.S. farmers identify as nonwhite or multiracial, according to the 2022 Census of Agriculture.US agriculture agency to end consideration of race, sex in many farm programs | ReutersThe Trump administration filed a lawsuit against California, arguing that the state's animal welfare laws concerning egg and poultry farming unlawfully raise egg prices nationwide and violate federal law. The complaint, brought in federal court in Los Angeles, claims that California's regulations conflict with the Egg Products Inspection Act of 1970, which mandates national uniformity in egg safety standards. The federal government asserts that only it has the authority to regulate egg safety and that California's restrictions burden interstate commerce.California laws passed by voter initiatives in 2008 and 2018 prohibit confining hens so tightly that they cannot move freely. These measures were designed to reduce animal cruelty and prevent foodborne illness. However, the federal government argues that while California can regulate farms within its borders, it cannot impose its requirements on out-of-state producers selling eggs in California.This is not the first legal battle over the issue. In 2014, several states sued California on similar grounds and lost at both the district and appellate levels. The U.S. Supreme Court upheld California's 2018 animal welfare measure in a separate challenge from pig farmers in 2023, further solidifying the state's right to set agricultural standards for products sold within its borders.US government sues California over egg prices | Reuters This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.minimumcomp.com/subscribe

Plus, Linda Yaccarino steps down as CEO of X after two years on the job. And U.S. measles cases hit a 33-year high. Alex Ossola hosts. Sign up for the WSJ's free What's News newsletter.  Learn more about your ad choices. Visit megaphone.fm/adchoices

Listen for the latest from Bloomberg News See omnystudio.com/listener for privacy information.

Top headlines for Tuesday, July 8, 2025In this episode, we begin with the heartbreaking news of the tragic loss of 27 camp attendees and counselors at a Christian girls summer camp in Texas due to severe flooding. Our thoughts and prayers go out to all affected by this calamity. Next, we explore the controversy stirred by author and Dietrich Bonhoeffer biographer Eric Metaxas, who recently criticized The Episcopal Church for their use of Bonhoeffer's legacy in political discourse against President Donald Trump. Finally, we highlight a groundbreaking development in Christian media as Minno announces the launch of the first American Sign Language Bible series for children, making scripture more accessible to the deaf and hard of hearing community. 00:11 27 girls confirmed dead in floods at Texas Christian Camp Mystic01:12 Eric Metaxas blasts Episcopal leader for invoking Bonhoeffer02:03 Study links marijuana use to heart failure03:00 TD Jakes hands over leadership of The Potter's House to daughter04:05 6 states form new accreditation agency to counter 'woke' monopoly05:02 Minno launches American Sign Language Bible series for kidsSubscribe to this PodcastApple PodcastsSpotifyGoogle PodcastsOvercastFollow Us on Social Media@ChristianPost on TwitterChristian Post on Facebook@ChristianPostIntl on InstagramSubscribe on YouTubeGet the Edifi AppDownload for iPhoneDownload for AndroidSubscribe to Our NewsletterSubscribe to the Freedom Post, delivered every Monday and ThursdayClick here to get the top headlines delivered to your inbox every morning!Links to the News27 girls confirmed dead in floods at Texas Christian Camp Mystic | U.S.Eric Metaxas blasts Episcopal leader for invoking Bonhoeffer | U.S.Study links marijuana use to heart failure | WorldTD Jakes hands over leadership of The Potter's House to daughter | Church & Ministries6 states form new accreditation agency to counter 'woke' monopoly | EducationMinno launches American Sign Language Bible series for kids | Church & Ministries

“The five-year relative survival rate for localized, or cancer that is confined to the colon or the rectum, is 91% for colon cancer and 90% for rectal cancer. Distant, metastasized to other organs—the five-year survival rate is 13% for colon and 18% for rectal cancer. So that really shows you the huge difference in screening and where screening can come in and make better outcomes,” ONS member Kris Mathey, DNP, APRN-CNP, AOCNP®, gastrointestinal medical oncology nurse practitioner at The James Cancer Hospital of The Ohio State University Wexner Medical Center, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a conversation about colorectal cancer screening. Music Credit: “Fireflies and Stardust” by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0  Earn 0.75 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by July 4, 2026. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Leaners will report an increase in knowledge related to colorectal screening, early detection, and disparities. Episode Notes Complete this evaluation for free NCPD. ONS Podcast™ episode: Episode 153: Metastatic Colorectal Cancer Has More Treatment Options Than Ever Before ONS Voice articles: AI-Assisted Colonoscopy Can Detect Small Colon Polyps As Colorectal Cancer Incidence Increases in Younger Patients, USPSTF Issues New Screening Guidelines. Here's How Nurses Can Encourage Uptake Colorectal Cancer Prevention, Screening, Treatment, and Survivorship Recommendations Text Messaging Reduces Disparities in Colorectal Cancer Screening USPSTF Recommends Colorectal Cancer Screening Should Begin at 45 Clinical Journal of Oncology Nursing articles: Colorectal Cancer in Young Adults: Considerations for Oncology Nurses Colorectal Cancer Screening: A Quality Improvement Initiative Using a Bilingual Patient Navigator, Mobile Technology, and Fecal Immunochemical Testing to Engage Hispanic Adults Oncology Nursing Forum article: Disparities in Cancer Screening in Sexual and Gender Minority Populations: A Secondary Analysis of Behavioral Risk Factor Surveillance System Data ONS Course: Prevention, Detection, and the Science of Cancer—Oncology RN ONS Biomarker Database ONS Colorectal Cancer Learning Library American Cancer Society colorectal cancer resources Colorectal Cancer Alliance To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode “Interestingly, recent studies suggest that starting screening even earlier than 45, such as age 40, could significantly reduce mortality and incidence rates, especially as colorectal cancer is rising among younger adults.” TS 2:42 “[Artificial intelligence]-enhanced screening tools are also being developed to improve sensitivity, reduce turnaround time, and enable real-time monitoring of disease progression. These innovations aim to make screening more accessible and accurate, especially in our underserved populations. So there's a huge impact on early detection.” TS 4:07 “Those with multiple chronic conditions or limited mobility may be less likely to complete screening, and those results may be harder to interpret. I mentioned a little bit earlier about our underserved or minority populations. Those barriers such as limited health literacy, lack of insurance, and cultural stigma can reduce screening uptake and ultimately follow-through.” TS 12:25 “Patient navigation programs—this is where we have trained navigators to help patients schedule appointments, understand procedures, and ultimately overcome some of these logistical hurdles. These have actually been shown to significantly boost screening rates. Also, those mailed stool-based-test kits—sending those kits directly to a patient home, especially with a personalized letter from a provider to add that extra little touch, has proven effective in increasing participation.” TS 21:29 “Our screening can detect cancer before symptoms appear and even identify precancerous polyps, which can be removed to prevent cancer altogether. Studies actually show that regular screening can reduce colorectal cancer mortality by up to 35% and the incidence of advanced-stage disease by nearly 30%. Just another reason why screening really does matter.” TS 25:53 “Evaluating our implicit bias, especially in something as critical as colorectal cancer, requires both introspection and instructional supports. One way of doing this is by auditing your practice patterns, really looking at reviewing your own screening recommendations and follow-up rates across different patient demographics. So are there certain groups that are less likely to be offered a colonoscopy? I think some of us may have an implicit bias—you see a patient; you're like, ‘There's no way they're going to agree to that, so I'm just not going to offer it.' Where we don't offer it, they don't have that opportunity to decline that. That can lead to further delay. And those patterns can reveal a bias in action.” TS 28:18

Ever wonder what happens when you invest in a syndication? In this episode, hosts Tait Duryea and Ryan Gibson break down how real estate syndications work, from deal sourcing and underwriting to legal docs, fees, and investor returns. Learn how passive investors get access to large-scale deals, what to look for in a sponsor, and what happens after you wire the funds. If you're considering a syndication, this is your essential primer.Show notes:(0:00) Intro(03:11) Why syndications open new doors(05:02) What is a real estate syndication?(07:20) Inside a $102M portfolio deal(09:50) How deals are sourced and vetted(11:38) Fee structures: who gets what(17:13) Key documents: PPM, OA, subscription(23:28) How to title your investment(29:20) Accreditation: requirements and process(37:58) What happens after you invest(42:00) Outro

The P. Diddy Verdict is in! Joyce shares her thoughts on it! She also talks about the spiteful rename of the Big Beautiful Bill, Elon Musk fighting with President Trump, Colombia University in jeopardy of losing it's accreditation status over Israel war protests, Life guards making 6 figures in Los Angeles, and more. Author C.J. Piperata calls in to talk about her book "Awaken Archangel," a religious scientific fantasy. See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Send us a textCaleb and James explore the 150 year long breeding legacy of complex Paphiopedilums, from historic species to modern show-stopping hybrids and the breeders that create them.Thanks for listening to The Orchid Pod. Send us an email at theorchidpod@gmail.com or leave us a voicemail/text at +1-678-6ORCHID (+1-678-667-2443 - Standard rates apply)

Send us a textWelcome to another inspiring episode of Living the Dream with Curveball! Join us as we dive into the impactful journey of Tava Scott, CEO and chief consultant of T. Scott Consulting. Tava shares her profound experiences in social services, from her early days in Louisiana to her current mission of elevating care standards across multiple states. Discover how her passion for helping others led to the creation of a consulting firm dedicated to improving service quality for vulnerable populations. Tava discusses the challenges faced by agencies, the importance of compliance, and the innovative solutions her team provides to ensure that those in need receive the best care possible. With a wealth of knowledge and a heart for service, Tava's insights will motivate you to find ways to support your community and make a difference.1. Introduction to Tava Scott and her background2. The journey into social services and the inspiration behind T. Scott Consulting3. The importance of quality service in behavioral health programs4. Achievements and recognition in the field5. Upcoming projects and conferences6. Final thoughts on community support and collaborationFor more information on Tava and her work, visit T. Scott Consulting or reach out via LinkedIn. Don't forget to subscribe to the Living the Dream with Curveball podcast for more uplifting stories and insights!Want to be a guest on Living the Dream with Curveball? Send Curtis Jackson a message on PodMatch, here: https://www.podmatch.com/hostdetailpreview/1628631536976x919760049303001600

CRESA will undergo an on-site accreditation review starting July 7 to maintain its status with CALEA, the national authority for public safety communications standards. Residents are invited to comment as part of the evaluation process. https://www.clarkcountytoday.com/news/calea-accreditation-assessor-invites-public-comment/ #CRESA #publicsafety #CALEA #ClarkCounty #emergencyservices #accreditation #lawenforcement #telecommunications #JulieRighterDove

Good news / bad news. The good news is that the ongoing military confrontation with Iran has not yet spilled over into a full-blown war. The bad news is that Florida Governor Ron DeSantis is taking his ball and going home, starting his own parallel, anti-woke, university accrediting agency. Is it a good thing for there to be separate education systems for liberals and conservatives? Should we ever meet or interact with people who don't agree with us? Drs. Tim Slekar and Johnny Lupinacci certainly have their thoughts on the matter. So join us as BustED Pencils takes on the Confederacy of Accreditation. BustED Pencils: Fully Leaded Education Talk is part of Civic Media. Subscribe to the podcast to be sure not to miss out on a single episode! Go to bustedpencils.com for swag, all of our episodes, and for information on partnering with us! For information on all of the programming across the Civic Media network, head over to https://civicmedia.us/shows. Join the conversation by calling or texting us at 608-557-8577 to leave a message!

“Just remember that these patients, these are human beings who had lung cancer. It's a scary disease. And we don't want to just say, ‘Oh, well, that's a horrible disease. They probably won't do well.' These patients are living longer. Our treatments are better. And so no matter who they are, they have every chance of surviving long term for this,” ONS member Beth Sandy, MSN, CRNP, thoracic medical oncology nurse practitioner at the Abramson Cancer Center at the University of Pennsylvania in Philadelphia, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a conversation about lung cancer survivorship. Music Credit: “Fireflies and Stardust” by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0 Earn 0.5 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by June 27, 2026. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report an increase in knowledge related to lung cancer survivorship. Episode Notes  Complete this evaluation for free NCPD.  ONS Podcast™ episodes: Episode 363: Lung Cancer Treatment Considerations for Nurses Episode 359: Lung Cancer Screening, Early Detection, and Disparities ONS Voice articles: Nursing Considerations for Lung Cancer Survivorship Care Nurse-Led Survivorship Programs: Expert Advice to Help You Build Your Institution's Resources Oncology Nursing Forum articles: Empowering Lung Cancer Survivors in Post-Treatment Survivorship Care Using Participatory Action Research A Qualitative Cultural Sensitivity Assessment of the Breathe Easier Mobile Application for Lung Cancer Survivors and Their Families Exploring Stigma Among Lung Cancer Survivors: A Scoping Literature Review ONS Survivorship Care Plan Huddle Card ONS Survivorship Learning Library To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode “For patients with stage I disease, they have a pretty good chance of getting to that five-year mark, somewhere probably in the 70%–80% range, depending on if you're stage IA or IB. Then it starts to drop obviously if you go up stages with patients.” TS 6:36 “Our radiation oncologists … and the dosimetrists in radiation oncology do a great job trying to line those beams up to minimize toxicity to those other vital organs. But we just can't always do that. You may see long-term fibrotic changes within the lungs. You could see cardiac damage over time. You can see esophagitis or [gastrointestinal] toxicity, particularly in the esophagus over time, post-radiation. And just the fact of having disease or cancer in the lungs, you can have breathing problems and pulmonary issues long term.” TS 10:37 “Part of survivorship in lung cancer is smoking and smoking cessation. I know it can be hard for people to quit, even people who had curative-intent treatment for their lung cancer—and so keeping up with smoking cessation. And that can be hard again if you don't have access to a smoking cessation specialty or if you live with other people who smoke and don't have really access to programs to help you quit and help you stay quitting.” TS 17:26 “I should talk about autoimmune diseases as part of immunotherapy. We give immunotherapy now in the curative setting preoperatively, postoperatively, post-chemoradiation, so they may get a year or so of immunotherapy. They may develop some sort of autoimmune toxicity from that. Usually that will go away once we stop the immunotherapy. But I've seen some things persist over time. That can go anywhere from like mild eczema that came about to things like more serious, like maybe lupus or scleroderma that may have developed as part of your immunotherapy. And we may stop the immunotherapy, but that may linger on.” TS 25:02  

This isn't about pretending life is perfect. It's about learning how to create moments of magic, even in the middle of the mess.If we're not intentional about creating joy in our everyday lives, burnout isn't just possible... it's inevitable. Because here's the truth: hustle without harmony leads to resentment, exhaustion, and questioning why you even started in the first place.In this episode, I'm pulling back the curtain on something we don't talk about enough: the power of romanticizing your own life. Not as some indulgent luxury reserved for vacations or weekends, but as an absolutely essential strategy for sustaining your energy, your creativity, and your capacity to lead.. . . EPISODE CHAPTERS0:00 - Intro0:40 -  A Concept that's Empowering1:52 -   Am I Actually Enjoying My Life?2:26 - The Uncomfortable Truth4:44 -  Mental Shift6:07 -  Why Does Romanticizing our Lives Matter?8:04 - The Roses are out There10:22 - Choose to Celebrate Pleasure14:11 - Step Confidently into Life . . . RESOURCES ⁠⁠⁠The Vision Board Playbook: Design Your Dream Year⁠⁠⁠CONNECT WITH KANDULA⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Kandula Blogs⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Youtube⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠. . .ABOUT ANDREA DE LA CERDAAndrea De La Cerda is a highly accomplished communications professional with over 25 years of experience in the fields of advertising, communications and marketing. Throughout her career, Andrea has held key positions in renowned advertising agencies, brand consultancies and in-house marketing departments before creating Kandula. She possesses a deep understanding of consumer behavior and market trends, allowing her to develop innovative communication strategies that resonate with diverse audiences. Andrea received both her B.A. in Advertising and Business Administration and a M.A. in Education from Pepperdine. She is currently pursuing her Accreditation in Public Relations and is a member of PRSA.Sign up for Andrea's monthly newsletter, ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Insights for Systemic Change⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.. . .WORK WITH USKandula works with nonprofits, entrepreneurs, educational institutions, and established brands dedicated to expanding their influence and amplifying their impact through purpose-driven communication strategies. Reach out to work with us!

If you've ever found yourself staring at a life you didn't plan, wondering what comes next, this one's for you.This week, Andrea dives into the messy, beautiful, and often disorienting process of rebuilding your sense of self when life takes an unexpected turn. Whether you're navigating the end of a relationship, a career pivot, a health crisis, or another plot twist you didn't see coming—this episode offers real talk, reflective questions, and grounded inspiration to help you rediscover who you are when the old version of you no longer fits.  . . . RESOURCES » ⁠⁠⁠Boundaries Blueprint: 5-Minute Mental Health Tracker⁠⁠⁠» ⁠⁠⁠Get info about our upcoming Mastermind cohort!⁠⁠⁠⁠⁠⁠. . .CONNECT WITH KANDULAteam@kandulacommunications.com. . .CONNECT WITH KANDULA⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Kandula Blogs⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠YouTube⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠. . .ABOUT ANDREA DE LA CERDAAndrea De La Cerda is a highly accomplished communications professional with over 25 years of experience in the fields of advertising, communications and marketing. Throughout her career, Andrea has held key positions in renowned advertising agencies, brand consultancies and in-house marketing departments before creating Kandula. She possesses a deep understanding of consumer behavior and market trends, allowing her to develop innovative communication strategies that resonate with diverse audiences. Andrea received both her B.A. in Advertising and Business Administration and a M.A. in Education from Pepperdine. She is currently pursuing her Accreditation in Public Relations and is a member of PRSA.Sign up for Andrea's monthly newsletter, ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Insights for Systemic Change⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.. . .WORK WITH USKandula works with nonprofits, entrepreneurs, educational institutions, and established brands dedicated to expanding their influence and amplifying their impact through purpose-driven communication strategies. Reach out to work with us!

In this episode, Tom Varghese, MD, FACS, is joined by Brett Johnson, MD, and Clifford Ko, MD, FACS, from the American College of Surgeons (ACS). They discuss the recent article by Drs Johnson and Ko, “Evaluating Outcomes of Initial Site Visits Across American College of Surgeons Accreditation Programs,” in which the authors found that ACS accreditation identifies significant gaps in hospital quality, with only 61% of hospitals passing on their initial attempt. However, most ultimately succeed after remediation. These findings highlight that ACS accreditation both validates hospitals meeting rigorous standards and drives quality improvement in those that initially fall short. Disclosure Information: Drs Varghese, speaker, has no relevant financial conflicts to disclose. Drs Johnson and Ko, speakers, are employees of the American College of Surgeons. Learn more about the Journal of the American College of Surgeons, a monthly peer-reviewed journal publishing original contributions on all aspects of surgery, including scientific articles, collective reviews, experimental investigations, and more. #JACSOperativeWord

Did you know improper patient nutrition can severely impact your patient's outcomes? Join the co-hosts as they welcome patient nutrition expert Beth Quatrara for an eye-opening and insightful conversation about patient nutrition. Also, Beth shares some powerful ideas regarding how med-surg nurses can optimize their own nutrition during long shifts and once they get home. (AMSN Members Earn 0.5 CE Hours*) * This episode is eligible for 0.5 contact hours for AMSN members who listen to the episode and submit a completed evaluation through the online library. None of the individuals with the ability to control the content of this episode have any relevant financial relationships with ineligible companies to disclose. The Academy of Medical Surgical Nurses is an accredited provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.   SPECIAL GUEST Beth Quatrara, DNP, RN, CMSRN, ACNS-BC is a doctorally-prepared Clinical Nurse Specialist with over 25 years of nursing experience. The majority of her clinical career has been focused on caring for patients with digestive health concerns and associated nutritional complexities. She serves as the AMSN Nutrition liaison; working with AMSN members to amplify the nutritional care of their patients. She presents nationally and publishes on nutrition-related topics, as well as a host of clinically related issues. Dr Quatrara is an Associate Professor, and currently serves as the Program Lead for the MSN and DNP Graduate Programs at the University of Virginia School of Nursing.   MEET OUR CO-HOSTS Samantha Bayne, MSN, RN, CMSRN, NPD-BC is a nursing professional development practitioner in the inland northwest specializing in medical-surgical nursing. The first four years of her practice were spent bedside on a busy ortho/neuro unit where she found her passion for newly graduated RNs, interdisciplinary collaboration, and professional governance. Sam is an unwavering advocate for medical-surgical nursing as a specialty and enjoys helping nurses prepare for specialty certification.    Kellye' McRae, MSN-Ed, RN is a dedicated Med-Surg Staff Nurse and Unit Based Educator based in South Georgia, with 12 years of invaluable nursing experience. She is passionate about mentoring new nurses, sharing her clinical wisdom to empower the next generation of nurses. Kellye' excels in bedside teaching, blending hands-on training with compassionate patient care to ensure both nurses and patients thrive. Her commitment to education and excellence makes her a cornerstone of her healthcare team.   Marcela Salcedo, RN, BSN is a Floatpool nightshift nurse in the Chicagoland area, specializing in step-down and medical-surgical care. A member of AMSN and the Hektoen Nurses, she combines her passion for nursing with the healing power of the arts and humanities. As a mother of four, Marcela is reigniting her passion for nursing by embracing the chaos of caregiving, fostering personal growth, and building meaningful connections that inspire her work.   Eric Torres, ADN, RN, CMSRN is a California native that has always dreamed of seeing the World, and when that didn't work out, he set his sights on nursing.  Eric is beyond excited to be joining the AMSN podcast and having a chance to share his stories and experiences of being a bedside medical-surgical nurse.   Maritess M. Quinto, DNP, RN, NPD-BC, CMSRN is a clinical educator currently leading a team of educators who is passionately helping healthcare colleagues, especially newly graduate nurses. She was born and raised in the Philippines and immigrated to the United States with her family in Florida. Her family of seven (three girls and two boys with her husband who is also a Registered Nurse) loves to travel, especially to Disney World. She loves to share her experiences about parenting, travelling, and, of course, nursing!   Sydney Wall, RN, BSN, CMSRN has been a med surg nurse for 5 years. After graduating from the University of Rhode Island in 2019, Sydney commissioned into the Navy and began her nursing career working on a cardiac/telemetry unit in Bethesda, Maryland.  Currently she is stationed overseas, providing care for service members and their families.  During her free time, she enjoys martial arts and traveling.   

Episode 367: Pharmacology 101: PARP Inhibitors “We know that in cells that are proliferating very quickly, including cancer cells, single-strand DNA breaks are very common. When that happens, these breaks are often repaired by the PARP enzyme, and the cells can continue their replication process. If we block PARP, that repair cannot happen. So in blocking that, these single-strand breaks then lead to double-strand breaks, which ultimately is leading to cell apoptosis,” Danielle Roman, PharmD, BCOP, manager of clinical pharmacy services at the Allegheny Health Network Cancer Institute in Pittsburgh, PA, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a conversation about the PARP inhibitor drug class. Music Credit: “Fireflies and Stardust” by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0  Earn 0.5 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by June 13, 2026. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report an increase in knowledge related to the use of PARP inhibitors in cancer care. Episode Notes  Complete this evaluation for free NCPD.  ONS Podcast™ episodes: Pharmacology 101 series Episode 330: Stay Up to Date on Safe Handling of Hazardous Drugs Episode 232: Managing Fatigue During PARP Inhibitor Maintenance Therapy Episode 227: Biomarker Testing, PARP Inhibitors, and Oral Adherence During Ovarian Cancer Maintenance Therapy ONS Voice articles: PARP Inhibitors and Ovarian Cancer Genomics May Trick PARP Inhibitors to Treat More Cancers Oncology Drug Reference Sheet: Niraparib ONS books: Chemotherapy and Immunotherapy Guidelines and Recommendations for Practice (second edition) Clinical Guide to Antineoplastic Therapy: A Chemotherapy Handbook (fourth edition) Safe Handling of Hazardous Drugs (fourth edition) ONS courses: Safe Handling Basics Clinical Journal of Oncology Nursing articles: PARP Inhibition: Genomics-Informed Care for Patients With Malignancies Driven by BRCA1/BRCA2 Pathogenic Variants Talazoparib Plus Enzalutamide in Patients With HRR-Deficient mCRPC: Practical Implementation Steps for Oncology Nurses and Advanced Practice Providers Oncology Nursing Forum article: Familiarity and Perceptions of Ovarian Cancer Biomarker Testing and Targeted Therapy: A Survey of Oncology Nurses in the United States Oral Anticancer Medication Care Compass: Resources for Interprofessional Navigation ONS Biomarker Database ONS Oral Anticancer Medication Learning Library ONS Oral Anticancer Medication Toolkit Oral Chemotherapy Education Sheets To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To find resources for creating an ONS Podcast Club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode “The big toxicities here to watch for are primarily hematologic toxicities. It is one of those targeted therapies that does affect blood cell counts. So I'd say the blood cell count that is most commonly affected here is the hemoglobin. So, anemia very frequent complication that we see, probably a little bit more with olaparib compared with other drugs, but we see it as a class side effect. And we can also see neutropenia and thrombocytopenia with these agents, probably a little bit more with niraparib versus the others, but again, you can see it across all of these drugs.” TS 8:16 “We mentioned that rare risk of MDS and AML. This isn't a particularly scary thing if you talk to patients about it. Because of the rarity that we see this, it isn't something that we need to overemphasize, but I think careful monitoring of blood counts in is stressing the importance of that and early intervention here is very important.” TS 16:55 “This is a collaborative effort. And because of the home administration here, these patients do need to be followed very closely. So we are not laying eyes on them usually with the frequency that we do when we have patients actually coming into our infusion centers for treatments—so making sure that there is a plan for regular follow-up with these patients to ensure that they're getting that lab work done, that that's being looked at closely, that we're adjusting the dose if we need to based on that lab work, that we are managing the patient's fatigue. Again, that potentially dose reductions may be needed if patients are having that extreme fatigue.” TS 19:34 “I think one of those [misconceptions] could be that they're only effective in patients that have that BRCA1/2 mutation. And again, remember here that there is some data in particular disease states that we can use them and that they work in the absence of those mutations.” TS 25:12

In this timely episode, FAIR Executive Director Monica Harris, joined by Gabriel Nadales and Suzannah Alexander, examines the troubling rise of mandated ideological conformity across professional education programs with Zander Keig and Nafees Alam. Following FAIR's groundbreaking formal complaint to the Department of Education against CACREP (Council for Accreditation of Counseling and Related Education Programs) for compelling students to adopt specific ideological positions on race and privilege, the panel explores how similar patterns of coerced belief systems have infiltrated social work, medical, legal, and K-12 education programs nationwide. The discussion delves into real-world consequences for students who face academic penalties for expressing dissenting views or religious beliefs that conflict with prescribed ideologies, while offering concrete strategies for promoting genuine viewpoint diversity and protecting students' constitutional rights. As the conversation unfolds, the panelists thoughtfully consider whether FAIR's approach to challenging CACREP could serve as a model for addressing ideological conformity enforced by other accrediting bodies, such as the CSWE (Council on Social Work Education), ultimately asking whether the time has come for a broader movement to restore intellectual freedom and critical thinking in professional education.Podcast notesFAIR is a nonprofit, nonpartisan organization dedicated to advancing civil rights and liberties, and promoting a common culture grounded in fairness, understanding, and humanity. Check out FAIR at https://www.fairforall.org/ and their "American Experience Curriculum" at https://www.fairforall.org/american-experience-curriculum/

Let's get real: rejection stings. Whether it's a "no" to your proposal, a lost client, or a critical piece of feedback, it can shake your confidence and make you question everything. But here's something I wish I'd known sooner:Rejection isn't the end. It's often the pivot point toward deeper alignment and bigger success. . . . RESOURCES » ⁠⁠Boundaries Blueprint: 5-Minute Mental Health Tracker⁠⁠» ⁠⁠Get info about our upcoming Mastermind cohort!⁠⁠⁠⁠⁠. . .CONNECT WITH KANDULAteam@kandulacommunications.com. . .CONNECT WITH KANDULA⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Kandula Blogs⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠YouTube⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠. . .ABOUT ANDREA DE LA CERDAAndrea De La Cerda is a highly accomplished communications professional with over 25 years of experience in the fields of advertising, communications and marketing. Throughout her career, Andrea has held key positions in renowned advertising agencies, brand consultancies and in-house marketing departments before creating Kandula. She possesses a deep understanding of consumer behavior and market trends, allowing her to develop innovative communication strategies that resonate with diverse audiences. Andrea received both her B.A. in Advertising and Business Administration and a M.A. in Education from Pepperdine. She is currently pursuing her Accreditation in Public Relations and is a member of PRSA.Sign up for Andrea's monthly newsletter, ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Insights for Systemic Change⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.. . .WORK WITH USKandula works with nonprofits, entrepreneurs, educational institutions, and established brands dedicated to expanding their influence and amplifying their impact through purpose-driven communication strategies. Reach out to work with us!

The Trump administration has escalated its fight with Columbia University. We'll tell you why the family of the man charged in Boulder firebombing attack won't be deported. The US is the only country that vetoed a Gaza ceasefire resolution. Elon Musk is calling for a new policy bill as Republicans remain at odds. Plus, this small island could be the answer to supply chain woes. Learn more about your ad choices. Visit podcastchoices.com/adchoices

Crystal Yang talks about her research on the accreditation of jail-based health care. “The Hidden Health Care Crisis Behind Bars: A Randomized Trial to Accredit U.S. Jails” by Marcella Alsan and Crystal Yang. OTHER RESEARCH WE DISCUSS IN THIS EPISODE: “Impact of hospital accreditation on quality improvement in healthcare: A systematic review” by Mohammad J. Alhawajreh, Audrey S. Paterson, and William J. Jackson. “Improvement in quality of hospital care during accreditation: A nationwide stepped-wedge study" by Søren Bie Bogh, Anne Mette Falstie-Jensen, Erik Hollnagel, René Holst, Jeffrey Braithwaite, and Søren Paaske Johnsen. “Evaluating Accreditation” by Charles D. Shaw. "Mental Health and Criminal Involvement: Evidence from Losing Medicaid Eligibility" by Elisa Jácome. Probable Causation Episode 60: Elisa Jácome. "In-Kind Welfare Benefits and Reincarceration Risk: Evidence from Medicaid" by Marguerite Burns and Laura Dague. Probable Causation Episode 103: Marguerite Burns and Laura Dague. "Access to health Care and Criminal Behavior: Evidence form the ACA Medicaid Expansions" by Jacob Vogler. "The Effect of Medicaid Expansion on Crime Reduction: Evidence from HIFA-Waiver Expansions" by Hefei Wen, Jason M. Hockenberry, and Janet R. Cummings. “The Health Effects of Prison” by Randi Hjalmarsson and Matthew J. Lindquist. Probable Causation Episode 41: Matthew Lindquist. “The Effect of Incarceration on Mortality" by Samuel Norris, Matthew Pecenco, and Jeffrey Weaver.

Visit the Intensive Care Academy

IEW’s instructor accreditation program is back and better than ever! In this episode, Andrew Pudewa and Julie Walker sit down with Denise Kelley, Director of Product Development at IEW. They talk about the history and purpose of the accreditation program before explaining the new tiers of accreditation and the improved process for becoming accredited. If you want to know more about the new accreditation program, listen to this podcast and visit the IEW Accreditation Program web page. Referenced Materials IEW Accreditation Program Apply for IEW Accreditation Teaching Writing: Structure and Style® Seminar Structure and Style for Students IEW® Gradebook Transcript of Podcast Episode 479 If you have questions for Andrew, send them to podcast@IEW.comPerhaps your question will be answered at the next Ask Andrew Anything (AAA). If you have questions about IEW products or classes, contact customer service at 800.856.5815 or info@IEW.com